The effects of 5-HT(1A), 5-HT(1B) and 5-HT(1D) receptor agonists on trigeminal nociceptive neurotransmission in anaesthetized rats

European Journal of Pharmacology

Volumn 362, Issue 1, 1998, Pages 43-46

  Cumberbatch, Michael J ^a   Hill, Raymond G ^a   Hargreaves, Richard J ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

5 HT(1A) receptor; 5 HT(1B 1D) receptor; CP 93,129; Migraine; Zolmitriptan

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 3 (1,2,5,6 TETRAHYDRO 4 PYRIDYL)PYRROLO[3,2 B]PYRIDIN 5 ONE; SEROTONIN 1A AGONIST; SEROTONIN 1B AGONIST; SEROTONIN 1D AGONIST; SEROTONIN AGONIST; SEROTONIN RECEPTOR; ZOLMITRIPTAN; 3 (1,2,5,6 TETRAHYDROPYRID 4 YL)PYRROLO(3,2 B)PYRID 5 ONE; 3-(1,2,5,6-TETRAHYDROPYRID-4-YL)PYRROLO(3,2-B)PYRID-5-ONE; ANALGESIC AGENT; OXAZOLE DERIVATIVE; OXAZOLIDINONE DERIVATIVE; PYRIDINE DERIVATIVE; PYRROLE DERIVATIVE; TRYPTAMINE DERIVATIVE;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ELECTROSTIMULATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MENINGEAL ARTERY; MIGRAINE; NEUROTRANSMISSION; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; TRIGEMINAL NUCLEUS; ANIMAL; CLASSIFICATION; SPRAGUE DAWLEY RAT;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ACTION POTENTIALS; ANALGESICS; ANIMALS; ELECTRIC STIMULATION; MALE; MIGRAINE DISORDERS; OXAZOLES; OXAZOLIDINONES; PYRIDINES; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; TRIGEMINAL CAUDAL NUCLEUS; TRYPTAMINES;

EID: 0032217263     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00764-X     Document Type: Article

References (19)

1. 1D receptor messenger RNA and ligand binding sites in guinea-pig brain and trigeminal ganglion: clues for function. Neuroscience 82, 469-484.
2. 1B receptor messenger RNA in neurons of the rat trigeminal ganglia. Eur. J. Pharmacol. 227, 357-359.
3. 1D binding sites in human and guinea-pig brain using different radioligands. Mol. Brain Res. 21, 19-29.
4. Ceci, A., Baschirotto, A., Borsini, F., 1994. The inhibitory effect of 8-OH-DPAT on the firing activity of dorsal raphe serotoninergic neurons in rats is attenuated by lesion of the frontal cortex. Neuropharmacology 33, 709-713.
5. Cumberbatch, M.J., Hill, R.G., Hargreaves, R.J., 1997. Rizatriptan has central antinociceptive effects against durally evoked responses. Eur. J. Pharmacol. 328, 37-40.
6. Fozard, J.R., Mir, A.K., Middlemiss, D.N., 1987. Cardiovascular response to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysis. J. Cardiovasc. Pharmacol. 9, 328-347.
7. 1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine?. Pain 67, 355-359.
8. Goadsby, P.J., Knight, Y.E., 1997a. Direct evidence for central sites of action of zolmitriptan (311C90): an autoradiographic study in cat. Cephalalgia 153-158.
9. 1B/1D) receptors. Br. J. Pharmacol. 122, 918-922.
10. Humphrey, P.P., Feniuk, W., 1991. Mode of action of the anti-migraine drug sumatriptan. Trends Pharmacol. Sci. 12, 444-446.
11. 1B-immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new antimigraine drugs. Cephalalgia 17, 833-842.
12. 1B) agonist and rotationally restricted phenolic analogue of 5-methoxy-3-(l,2,5,6-tetrahydropyrid-4-yl)indole. J. Med. Chem. 33, 2087-2093.
13. 1B/1D agonist for migraine. Cephalalgia 17 (18), 4-14.
14. Moskowitz, M.A., 1992. Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol. Sci. 13, 307-311.
15. 1B/1D receptor agonists on neurogenic dural plasma extravasation and vasodilation in anaesthetized rats. Neuropharmacology 36, 525-533.
16. 1B/1D agonists inhibits trigeminal cell firing in the cat. Brain 120, 2171-2177.
17. 1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets. Neuropharmacology 35, 1121-1129.
18. van Wijngaarden, I., Tulp, M.T., Soudijn, W., 1990. The concept of selectivity in 5-HT receptor research. Eur. J. Pharmacol. 188, 301-312.
19. Williamson, D.J., Hargreaves, R.J., Hill, R.G., Shepheard, S.L., 1997. Sumatriptan inhibits neurogenic vasodilation of durai blood vessels in the anaesthetized rat - intravital microscope studies. Cephalalgia 17, 525-531.